Since the predictive value of NAb activity for immune protection from symptomatic COVID-19 and IgG, IgA values from various disease events were shown, evaluation of Nab activity and antibody titers on correlation with their Nab activity in different groups is worthwhile [24, 25]. This evidence concerns the gene CD79A and COVID-19.